Casual Nexus – Episode One: Formulation Development and Clinical Supply of Aseptic Liposomal

webinar

Drug Product

Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function that can support accelerated timelines to clinic, including complex formulations Recent and ongoing experiences in liposomal formulations, with focus on high pressure homogenization Linearity of laboratory to clinical supply scale-up with supporting analytics Broad applicability to variety of product types and presentations (liquid, lyophilized, potent compounds, cytotoxics

View resource

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

More from Curia

webinar

Ensuring Patient Safety: Decoding FDA’s Rating System for CDMOs

This program aims to encourage drug manufacturers to implement quality management practices that go beyond current good manufacturing practice (CGMP) requirements.

webinar

In Pursuit of High Concentration Protein Formulation

In this webinar, we critically review the molecular intricacies behind these challenges and propose a systematic exploration of the formulation space to identify excipients conducive to high concentration formulations.